Search research articles
Contact Us
Filters
Showing results (11-20 of 223) with videos related to
Page
of 23
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
May 25, 1999
Chemoprevention of human cancer: a reasonable strategy?
F L Meyskens
IARC Scientific Publications
|
February 28, 2001
Development of difluoromethyl-ornithine and Bowman-Birk inhibitor as chemopreventive agents by assessment of relevant biomarker modulation: some lessons learned
F L Meyskens
Journal of the National Cancer Institute. Monographs
|
January 11, 1992
Biomarker intermediate endpoints and cancer prevention
F L Meyskens
Lancet (London, England)
|
July 23, 1983
Radiation sensitivity of clonogenic human melanoma cells
F L Meyskens
Progress in Clinical and Biological Research
|
January 1, 1988
Biology of human melanoma colony-forming cells
F L Meyskens
Oncology (Williston Park, N.Y.)
|
February 11, 1992
Strategies for prevention of cancer in humans
F L Meyskens
Journal of the National Cancer Institute
|
December 21, 1988
Evolution of Cancer Prevention and Control Program at the Arizona Cancer Center
F L Meyskens
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2000
Cancer population genetics and tumour prevention: an unfulfilled paradigm
F L Meyskens
Journal of Cellular Biochemistry. Supplement
|
April 13, 2000
Criteria for implementation of large and multiagent clinical chemoprevention trials
F L Meyskens
Journal of the National Cancer Institute
|
March 24, 1999
Re: Cancer chemoprevention: progress and promise
F L Meyskens
Page
of 23
Search research articles
Search
Showing results (11-20 of 223) with videos related to
Sort By:
Page
of 23
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
May 25, 1999
Chemoprevention of human cancer: a reasonable strategy?
F L Meyskens
IARC Scientific Publications
|
February 28, 2001
Development of difluoromethyl-ornithine and Bowman-Birk inhibitor as chemopreventive agents by assessment of relevant biomarker modulation: some lessons learned
F L Meyskens
Journal of the National Cancer Institute. Monographs
|
January 11, 1992
Biomarker intermediate endpoints and cancer prevention
F L Meyskens
Lancet (London, England)
|
July 23, 1983
Radiation sensitivity of clonogenic human melanoma cells
F L Meyskens
Progress in Clinical and Biological Research
|
January 1, 1988
Biology of human melanoma colony-forming cells
F L Meyskens
Oncology (Williston Park, N.Y.)
|
February 11, 1992
Strategies for prevention of cancer in humans
F L Meyskens
Journal of the National Cancer Institute
|
December 21, 1988
Evolution of Cancer Prevention and Control Program at the Arizona Cancer Center
F L Meyskens
European Journal of Cancer (Oxford, England : 1990)
|
July 7, 2000
Cancer population genetics and tumour prevention: an unfulfilled paradigm
F L Meyskens
Journal of Cellular Biochemistry. Supplement
|
April 13, 2000
Criteria for implementation of large and multiagent clinical chemoprevention trials
F L Meyskens
Journal of the National Cancer Institute
|
March 24, 1999
Re: Cancer chemoprevention: progress and promise
F L Meyskens
Page
of 23